738
Views
20
CrossRef citations to date
0
Altmetric
Research Paper

Potential impact of the bivalent rLP2086 vaccine on Neisseria meningitidis carriage and invasive serogroup B disease

, , , , , , , & show all
Pages 471-479 | Received 17 Oct 2012, Accepted 29 Oct 2012, Published online: 18 Dec 2012

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (6)

Leonardo Terranova, Nicola Principi, Sonia Bianchini, Giada Di Pietro, Giulia Umbrello, Barbara Madini & Susanna Esposito. (2018) Neisseria meningitidis serogroup B carriage by adolescents and young adults living in Milan, Italy: Prevalence of strains potentially covered by the presently available meningococcal B vaccines. Human Vaccines & Immunotherapeutics 14:5, pages 1070-1074.
Read now
Elena Gianchecchi, Giulia Piccini, Alessandro Torelli, Rino Rappuoli & Emanuele Montomoli. (2017) An unwanted guest: Neisseria meningitidis – carriage, risk for invasive disease and the impact of vaccination with insight on Italy incidence. Expert Review of Anti-infective Therapy 15:7, pages 689-701.
Read now
Ashesh Gandhi, Paul Balmer & Laura J. York. (2016) Characteristics of a new meningococcal serogroup B vaccine, bivalent rLP2086 (MenB-FHbp; Trumenba®). Postgraduate Medicine 128:6, pages 548-556.
Read now
Kate L Seib, Maria Scarselli, Maurizio Comanducci, Daniela Toneatto & Vega Masignani. (2015) Neisseria meningitidis factor H-binding protein fHbp: a key virulence factor and vaccine antigen. Expert Review of Vaccines 14:6, pages 841-859.
Read now
Nathan James Brendish & Robert Charles Read. (2015) Neisseria meningitidis serogroup B bivalent factor H binding protein vaccine. Expert Review of Vaccines 14:4, pages 493-503.
Read now

Articles from other publishers (14)

Alessia Biolchi, Gabriella De Angelis, Monica Moschioni, Sara Tomei, Brunella Brunelli, Maria Giuliani, Stefania Bambini, Ray Borrow, Heike Claus, Maria Cecilia O. Gorla, Eva Hong, Ana Paula S. Lemos, Jay Lucidarme, Muhamed-Kheir Taha, Ulrich Vogel, Maurizio Comanducci, Sonia Budroni, Marzia M. Giuliani, Rino Rappuoli, Mariagrazia Pizza & Philip Boucher. (2020) Multicomponent meningococcal serogroup B vaccination elicits cross-reactive immunity in infants against genetically diverse serogroup C, W and Y invasive disease isolates. Vaccine 38:47, pages 7542-7550.
Crossref
Matt Shirley & Muhamed-Kheir Taha. (2018) MenB-FHbp Meningococcal Group B Vaccine (Trumenba®): A Review in Active Immunization in Individuals Aged ≥ 10 Years. Drugs 78:2, pages 257-268.
Crossref
Manish Sadarangani. 2018. The Microbiology of Central Nervous System Infections. The Microbiology of Central Nervous System Infections 61 79 .
Raquel Abad, Verónica Medina, Maria del Carmen Fariñas, Luis Martínez-Martínez, Stefania Bambini, A. Dari, Duccio Medini, Mariagrazia Pizza & Julio A. Vázquez. (2017) Potential impact of the 4CMenB vaccine on oropharyngeal carriage of Neisseria meningitidis. Journal of Infection 75:6, pages 511-520.
Crossref
M. Sadarangani & A.J. Pollard. (2016) Can we control all-cause meningococcal disease in Europe?. Clinical Microbiology and Infection 22, pages S103-S112.
Crossref
Stephen A. Clark, Aiswarya Lekshmi, Jay Lucidarme, Li Hao, How Tsao, Lisa Lee-Jones, Kathrin U. Jansen, Lynne S. Newbold, Annaliesa S. Anderson & Ray Borrow. (2016) Differences between culture & non-culture confirmed invasive meningococci with a focus on factor H-binding protein distribution. Journal of Infection 73:1, pages 63-70.
Crossref
C. Hal Jones, Naglaa Mohamed, Eduardo Rojas, Lubomira Andrew, Johanna Hoyos, Julio C. Hawkins, Lisa K. McNeil, Qin Jiang, Leonard W. Mayer, Xin Wang, Rodica Gilca, Philippe De Wals, Louise Pedneault, Joseph Eiden, Kathrin U. Jansen & Annaliesa S. Anderson. (2016) Comparison of Phenotypic and Genotypic Approaches to Capsule Typing of Neisseria meningitidis by Use of Invasive and Carriage Isolate Collections. Journal of Clinical Microbiology 54:1, pages 25-34.
Crossref
Shruti Sridhar, Brian Greenwood, Christopher Head, Stanley A Plotkin, Marco A Sáfadi, Samir Saha, Muhamed-Kheir Taha, Oyewale Tomori & Bradford D Gessner. (2015) Global incidence of serogroup B invasive meningococcal disease: a systematic review. The Lancet Infectious Diseases 15:11, pages 1334-1346.
Crossref
Matt Shirley & Sohita Dhillon. (2015) Bivalent rLP2086 Vaccine (Trumenba®): A Review in Active Immunization Against Invasive Meningococcal Group B Disease in Individuals Aged 10–25 Years. BioDrugs 29:5, pages 353-361.
Crossref
R. Gasparini, D. Panatto, N. L. Bragazzi, P. L. Lai, A. Bechini, M. Levi, P. Durando & D. Amicizia. (2015) How the Knowledge of Interactions between Meningococcus and the Human Immune System Has Been Used to Prepare Effective Neisseria meningitidis Vaccines . Journal of Immunology Research 2015, pages 1-26.
Crossref
Roberto Gasparini, Maurizio Comanducci, Daniela Amicizia, Filippo Ansaldi, Paola Canepa, Andrea Orsi, Giancarlo Icardi, Emanuela Rizzitelli, Gabriella De Angelis, Stefania Bambini, Monica Moschioni, Sara Comandi, Isabella Simmini, Giueseppe Boccadifuoco, Brunella Brunelli, Marzia Monica Giuliani, Mariagrazia Pizza & Donatella Panatto. (2014) Molecular and Serological Diversity of Neisseria meningitidis Carrier Strains Isolated from Italian Students Aged 14 to 22 Years. Journal of Clinical Microbiology 52:6, pages 1901-1910.
Crossref
Susan K. Hoiseth, Ellen Murphy, Lubomira Andrew, Ulrich Vogel, Matthias Frosch, Wiebke Hellenbrand, Raquel Abad, Julio A. Vazquez, Ray Borrow, Jamie Findlow, Muhamed-Kheir Taha, Ala-Eddine Deghmane, Dominique A. Caugant, Paula Kriz, Martin Musilek, Leonard W. Mayer, Xin Wang, Jessica R. MacNeil, Laura York, Charles Y. Tan, Kathrin U. Jansen & Annaliesa S. Anderson. (2013) A Multi-country Evaluation of Neisseria meningitidis Serogroup B Factor H–Binding Proteins and Implications for Vaccine Coverage in Different Age Groups. Pediatric Infectious Disease Journal 32:10, pages 1096-1101.
Crossref
Lisa K. McNeil, Robert J. Zagursky, Shuo L. Lin, Ellen Murphy, Gary W. Zlotnick, Susan K. Hoiseth, Kathrin U. Jansen & Annaliesa S. Anderson. (2013) Role of Factor H Binding Protein in Neisseria meningitidis Virulence and Its Potential as a Vaccine Candidate To Broadly Protect against Meningococcal Disease. Microbiology and Molecular Biology Reviews 77:2, pages 234-252.
Crossref
Nicole M. Caesar, Kenneth A. Myers & Xin Fan. (2013) Neisseria meningitidis serogroup B vaccine development. Microbial Pathogenesis 57, pages 33-40.
Crossref